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Abstract
Diabetes is becoming more prevalent in the UK and this is represented in the in-patient cohort, such that 1 in 6 hospital patients have diabetes
(1). The UK National Diabetes In-Patient Audit in 2012 estimated that 30% of patients experience one episode of hypoglycaemia during
admission. Hypoglycaemia is associated with increased morbidity and mortality, and longer length of hospital stay.
It is therefore important that hypoglycaemia is managed promptly and effectively to reduce associated morbidity. The Joint British Diabetes
Society recommends that all wards should have access to ‘Hypo Boxes’ (2).
We assessed all episodes of hypoglycaemia (<4.0 mmol/l) in the diabetes wards in over a 4 week period. ‘Hypo Boxes’ were installed to the
wards and the appropriateness of treatment and time to correction of hypoglycaemia was re-assessed.
Assessment of hypoglycaemia pre-intervention revealed 45 episodes of hypoglycaemia in 14 patients, and 42% (n=19) of episodes were
deemed to have been treated appropriately. Only 17.8% of episodes were corrected within 30 minutes, and 33.3% were corrected within 60
minutes. A third of patients (35%) did not have a further blood glucose checked.
Following intervention, there was a marked improvement in management. The proportion of appropriately managed episodes increased to
82% (n=35) and management of episodes of severe hypoglycaemia (<3.0 mmol/l) increased to 94%. The time to correction increased with
40% of episodes corrected to >4.0 mmol/l within 30 minutes, and a further 54% between 30-60 minutes.
In conclusion, the introduction of ‘Hypo Boxes’ improved the assessment and management of hypoglycaemia.
Problem
Hypoglycaemia is a well-recognised complication in patients with
diabetes mellitus on insulin or sulphonylurea therapy. It represents
a significant barrier to achieving optimal glycaemic control.
Hypoglycaemia in hospital in-patients is increasingly common,
mainly due to the increasing prevalence of type 2 diabetes in the
UK population and a subsequent increase in the number of patients
who have diabetes as a co-existing medical condition. The Joint
British Diabetes Society estimate that 1 in 6 hospital in-patients will
have diabetes (2).
Hypoglycaemia has been shown to be associated with serious
adverse outcomes. Specifically, it is associated with an increase in
hospital mortality, as well as a longer length of hospital stay (3).
This relationship is dose dependent; both the length of stay and in-
patient mortality increased as the number and/or severity of
hypoglycaemic episodes increased (3). Previous work has
demonstrated a strong association with the number of episodes of
hypoglycaemia following one admission, and outpatient mortality at
one year (3).
The UK National Diabetes In-patient Audit in 2012 demonstrated
that 20.4% of in-patients with diabetes had at least one episode of
minor hypoglycaemia (3-3.9mmol/L) and 10.5% had at least one
episode of severe hypoglycaemia (<3 mmol/L) (1). These episodes
tend to not be treated appropriately, and patients are often given
tea and toast, or biscuits, which provide an unpredictable glycaemic
response and contain unnecessary saturated fats. The In-patient
Audit also demonstrated that 39.8% of patients experienced at least
one diabetes medication error, and these patients were twice as
likely to experience a severe hypoglycaemic episode (16.8%),
compared to those who did not have a medication error (1).
Hypoglycaemia in hospitalised patients with diabetes is becoming
more prevalent and is associated with significant adverse
outcomes. Therefore, prompt recognition and appropriate and
effective management of hypoglycaemia is essential to improve
patient outcomes. The Joint British Diabetes Society recommends
that all hospital wards should have access to ‘Hypo Boxes’ to
promote the correct management of these episodes (2).
Background
There has been a huge increase in the number of people with
diabetes, and it is now one of the biggest health challenges facing
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the UK today. Between 1996 and 2012 the number of people
diagnosed with diabetes mellitus in the UK increased from 1.4
million to 2.9 million people, and it is estimated that by 2025 there
will be 5 million people with diabetes. The majority of these patients
will have type 2 diabetes, which is largely due to the combination of
an ageing population and the increasing numbers of overweight and
obese patients (4).
Type 1 and type 2 diabetes mellitus affects 5% of the Scottish
population (Scottish Diabetes Survey 2013) (5). The UK In-Patient
Audit has highlighted that approximately 17-20% of all in-patients
have diabetes and that 41.6% of these patients are managed with
insulin (1). The majority of patients in that audit were admitted for
medical reasons other than their diabetes (65.6%), and 8.2% were
admitted specifically for the management of their diabetes or a
complication of this (1). These numbers are likely to continue to
increase as the prevalence of diabetes continues to rise in the UK.
Patients with diabetes often have poorer outcomes, and this may be
attributed to episodes of glycaemic excursion due to acute illness.
The hospital environment poses additional risk factors which
increase the risk of hypoglycaemia, including (2):
Recovery from acute illness
Inappropriately timed insulin with meal times or enteral
feeding
Incorrect insulin doses prescribed or administered
Anorexia and vomiting secondary to acute illness
The elderly population may be more at risk of complications
associated with hypoglycaemia due to frailty, malnourishment,
polypharmacy, and other co-morbid conditions such as renal failure.
There may also be a delay in diagnosis of hypoglycaemia due to
cognitive impairment, reduced communication, or fewer adrenergic
symptoms (6).
Baseline measurement
The aim of this project was to improve the recognition and
appropriateness of management of episodes of hypoglycaemia
(<4.0 mmol/l). Our data collection tool was based on that of the
Joint British Diabetes Society guidance on The Hospital
Management of Hypoglycaemia in Adults with Diabetes Mellitus. It
included patient age and type of diabetes, usual treatment of
diabetes, the initial blood glucose reading, treatment administered,
blood glucose result post-treatment, as well as the time taken to
repeat blood glucose.
The initial baseline measurements were carried out over a 4 week
period throughout 3 diabetes wards in Glasgow Royal Infirmary. All
patients with type 1, type 2, or secondary diabetes were reviewed
with regard to any documented episodes of hypoglycaemia (<4.0
mmol/L) on finger prick glucose testing (Precision Xceed Pro
Glucometer). Episodes were only included if they occurred whilst on
these wards. They were excluded if they occurred prior to transfer
from medical receiving wards. These episodes were then reviewed
with regard to the treatment administered, whether this was
appropriate for the patient and the time to correction to a blood
glucose of >4.0mmol/l. Data was collected from bedside blood
glucose monitoring sheets, and information regarding treatment
was obtained from nursing and medical notes. If there was no
documentation of treatment then it was deemed to be inappropriate.
The appropriateness of management was based on the JBDS
Guidelines for managing hypoglycaemia and patients should be
given 15-20g of quick acting carbohydrate. If the patient is
conscious and co-operative then 150-200ml of fruit juice, 90-120ml
of lucozade, or 5-7 glucose tablets is the most appropriate
treatment. If the patient is alert but confused then the previous
options may be suitable, or 1.5 -2 tubes of Glucogel can be used.
Intramuscular glucagon may also be considered in this scenario if
glucogel is ineffective, although this is less effective in patients on
sulphonlyurea therapy. If the patient is unconscious, or nil by mouth
then 75-85ml of 20% dextrose or 150-160ml of 10% dextrose is
recommended therapy. These treatments should be repeated if the
blood glucose remains <4.0 mmol/l. These treatments should then
be followed by a longer acting carbohydrate, such as the patients
meal, 2 biscuits, or a glass of milk (2).
There were 45 episodes of hypoglycaemia which occurred in 14
patients in the pre-intervention group. This was an average of 3.2
episodes per patient (range 1-10 episodes). Five of these patients
had type 1 diabetes, eight had type 2 diabetes and one patient had
secondary diabetes due to alcohol excess and subsequent
pancreatic insufficiency. The 5 patients with type 1 diabetes were
on insulin therapy, as was the patient with secondary diabetes. Of
the 8 patients with type 2 diabetes, 4 of these were on insulin
monotherapy, 1 patient was on insulin and a GLP1 agonist
(liraglitide), 1 patient was on combination therapy with insulin and
glicalzide, and the remaining 2 patients were on oral hypoglycaemic
agents (sulphonylurea as monotherapy, and the other on
metformin, DPP4 inhibitor, and sulphonylurea). The average age of
the patients was 63 years (range 22-86 years).
There were 5 episodes detected with a blood glucose reading of
1.0-1.9 mmol/l, 18 episodes with a blood glucose reading of 2.0-2.9
mmol/l, and a further 22 episodes of hypoglycaemia with a blood
glucose between 3.0-3.9 mmol/l. All of these episodes of
hypoglycaemia with blood glucose on finger prick testing <4.0
mmol/l were assessed, and 19 episodes (42%) were treated
appropriately compared to JBDS guidelines. The remaining 26
episodes (58%) were deemed to be managed inappropriately.
These 45 episodes included 23 episodes of severe hypoglycaemia
with a BG of <3.0 mmol/l. Of these episodes of severe
hypoglycaemia, only 56% (n=13) were managed appropriately.
Eight of the total episodes (17.8%) were corrected within the
recommended 30 minutes. A third of episodes (33.3%) were
corrected within 60 minutes, and just over a third (35%) did not
have a blood glucose repeated for several hours.
See supplementary file: ds4959.doc - “Hypoglycaemia Management
Algorithm”
Design
  Page 2 of 4
© 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
group.bmj.com on December 24, 2015 - Published by http://qir.bmj.com/Downloaded from 
It had been noted that the management of in-patient diabetes, and
in particular hypoglycaemia, was sub-optimal and that episodes of
hypoglycaemia were being treated inadequately which was
potentially contributing to adverse patient outcomes. This occurred
throughout the hospital, but in particular in the diabetes wards
where such episodes were commonplace. The introduction of ‘Hypo
Boxes’ was therefore felt to be an important intervention to reduce
associated adverse outcomes with hypoglycaemia and address the
current inconsistency in the management.
The Joint British Diabetes Society recommends that all in-patient
wards should have access to Hypo Boxes that contain all the
necessary equipment to adequately manage an episode of
hypoglycaemia. These are placed in a prominent position on the
ward so that they are easily accessible by nursing and medical
staff. The audit collection tool and hypoglycaemia treatment
algorithm used was based on that of the JBDS guideline ‘The
Hospital Management of Hypoglycaemia of Hypoglycaemia in
Adults with Diabetes Mellitus’ (2). Appendix 1.
‘Hypo Boxes’ were introduced to the wards following discussions
with ward sister regarding the practicalities and objectives of the
boxes. As well as introducing ‘Hypo Boxes’, ward based education
was delivered on an informal basis to the nursing staff, and ward
sisters encouraged use of the boxes and algorithms. The contents
of the ‘Hypo Box’ used in our study were:
Copy of the hypoglycaemia algorithm
3 vials of glucogel (10g carbohydrate each)
3 packets of dextrose tablets (4g carbohydrate per tablet)
3 bottles of GlucoJuice (15g carbohydrate each)
Each episode of hypoglycaemia was recorded on a chart next to the
‘Hypo Boxes’ and each episode was further evaluated to assess
treatment. This was carried out in the same manner as for the pre-
intervention group. This was completed over a 4 week period.
Strategy
The first PDSA cycle’s aim was to collect data regarding episodes
of hypoglycaemia, and to design an easy to use data collection tool.
This focused on the treatment provided for episodes of
hypoglycaemia as well as the time to repeat blood glucose levels.
Over this 4 week period, our data collection improved so as to
ensure that no episodes of hypoglycaemia were missed. The
outcome of this cycle confirmed that episodes of hypoglycaemia
were being inadequately managed and patients were not having
repeat blood glucose testing performed in a timely manner. There
also seemed to be a lack of documentation surrounding these
episodes.
The second PDSA cycle involved increasing awareness of the
problem throughout key ward members of staff, including
awareness of the hypoglycaemia algorithm and recommended
treatment options, as well as the importance of recognising and
treating hypoglycaemia. We also gained approval from the wards to
implement a change, and specifically agreed for the introduction of
‘Hypo Boxes’. Our continued presence on the wards helped to
emphasise the importance and was a continual reminder to nursing
staff to assess these episodes of hypoglycaemia appropriately.
Inclusion of ward doctors also helped to further increase
awareness.
The third PDSA cycle involved the introduction of ‘Hypo Boxes’ to
the wards, along with printed copies of the hypoglycaemia
algorithm. The wards were given a 2 week period to allow them to
get use to the boxes and to deal with any problems that may arise
before data collection restarted. The ‘Hypo Boxes’ contained oral
glucose such as GlucoJuice, GlucoTabs and GlucoGel. The boxes
were located in easily accessible places and guidance on the use of
these was circulated throughout all members of ward staff. The
introduction demonstrated a marked improvement in both the
appropriateness of treatment given for episodes of hypoglycaemia,
as well as the time to correction. More patients had repeat blood
glucose levels checked to ensure resolution, and to assess the
need for further treatment.
The nursing staff found the ‘Hypo Boxes’ easy to use, accessible,
and practical. Health care assistants and members of medical staff
if present, as well as nursing staff, could use the ‘Hypo Box’. This
improvement was sustainable over the following 4 week
observation period and staff were more equipped to ensure
episodes were correctly managed. The medical staff on the wards
were also involved. The hope is that when they rotate jobs the new
medical staff will pick up from the nursing staff the significance of
the ‘Hypo Boxes’. Those doctors moving on will take this knowledge
and continue to promote good practice with regard to
hypoglycaemia in other hospital environments.
Results
Following intervention, there was a marked improvement in both the
appropriateness of management and the time to correction. In the 4
weeks following intervention, there were a similar number of
episodes with 43 episodes occurring in 23 patients. This was an
average of 1.8 episodes per patient (range 1-7 episodes). 10 of
these patients had type 1 diabetes mellitus and 13 patients had
type 2 diabetes (43% and 57% respectively). The 10 patients with
type 1 diabetes were on insulin monotherapy. Of the patients with
type 2 diabetes, 8 patients were on insulin therapy either as
monotherapy or in combination with oral hypoglycaemic agents.
The remaining 5 patients were on combination oral hypoglycaemic
therapy, and they all included a sulphonylurea. The average age
was 62 years (range 34-89 years).
The number of appropriately managed episodes improved, with
82% (n=35) of episodes managed appropriately (compared to 42%
pre-intervention). There were 3 episodes of hypoglycaemia with a
blood glucose of 1.0-1.9 mmol/l, 11 episodes between 2.0-2.9
mmol/l and 29 episodes of hypoglycaemia with a blood glucose
result 3.0-3.9 mmol/l. In the number of episodes of severe
hypoglycaemia (<3.0 mmol/l), the appropriateness in management
increased to 93% (n=13), with only 1 episode deemed to be treated
inappropriately. The time to correction also improved with 40% of
episodes being corrected within 30 minutes, and 54% corrected
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between 30 and 60 minutes. Overall, post-intervention 94% of
episodes were corrected within 60 minutes, compared to 51% pre-
intervention. There was 1 episode that was corrected within 90
minutes and only 2 episodes that did not have a further blood
glucose repeated, which were both mild hypoglycaemic episodes
between 3.5-3.9 mmol/l.
Lessons and limitations
This project emphasises the importance of involvement of all
members of the multidisciplinary team to promote good clinical
practice. The introduction of ‘Hypo Boxes’ was a simple intervention
that produced significant positive results and was easy to use and
readily accessible by all members of the team. We demonstrated
that the use of algorithms and protocols improve our practice and
can produce consistent and reproducible results, with the aim of
improving patient outcomes. Education and awareness play an
important role in encouraging the use of these guidelines. We would
hope that with continued education and exposure to guidelines that
we could achieve 100% of episodes being assessed and managed
appropriately.
There is still room for improvement however, and it may be that
further education and dissemination of the ongoing results to
nursing and medical staff may help to promote the importance of
good practice. This could include monthly run charts circulated to
staff and posted in ward areas, to continue to encourage members
of staff to adhere to the guidelines and strive to achieve better
results. This would also aim to maintain these results and ensure
that it becomes common practice.
Diabetes is becoming more prevalent and will be encountered in
almost every hospital specialty. It is therefore increasingly important
that this education is hospital wide and that ‘Hypo Boxes’ are
introduced to all clinical areas and made available to every ward
and department. This includes education to medical staff that rotate
jobs frequently as this knowledge and skill set can be implemented
in every job they encounter.
Although we demonstrated a significant improvement in results, the
management of in-patients diabetes is a large problem and there
are other areas that should be considered in future projects. This
includes the precipitant to hypoglycaemia and changes to
medications to prevent this reoccurring. Future projects should take
all these factors into consideration and continue to improve the in-
patient management of diabetes and any episodes of glycaemic
excursion.
Conclusion
We demonstrated that the introduction of ‘Hypo Boxes’ to diabetes
wards significantly improved the assessment and management of
episodes of hypoglycaemia. The appropriateness of treatment and
the time to correction improved, and ultimately this aims to improve
patient outcomes, something which can be adversely affected by
hypoglycaemia.
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